• About
  • Introduction
  • Innovators
  • Corporates
  • Case Studies
  • Content Hub
Leading Edge Only Leading Edge Only
  • Login
  • Join
About
Innovators
Corporates
Case Studies
Content Hub

Kristy Reynald

Queens University, Technology Transfer

This user is yet to add a description about themselves

Healthcare & Pharmaceuticals Medical Sciences Software & Platforms
User Verified
Last Active: 1 year ago
Register for free to view their full profile
Get Started

Connection Limit

You’ve reached your connections limit

Resets on {{ date }}

Contact us
  • Innovations
Published
Healthcare & Pharmaceuticals

Methylation Liquid Biopsy

mDETECT - A next-generation sequencing methylation-based blood test for detection and monitoring of TNBC

By Queen’s University

Reference Number   08977

Last Update   May 04, 2022

Published
Healthcare & Pharmaceuticals

IOP Monitoring Contact Lens

Novel low-cost device for accurate, non-invasive IOP monitoring using a mobile phone.

By Queen’s University

Reference Number   08978

Last Update   May 04, 2022

Published
Healthcare & Pharmaceuticals

MMP-14 antibodies for cancer

Novel synthetic antibody that limits tumor progression and metastasis.

By Queen’s University

Reference Number   08979

Last Update   May 04, 2022

Published
Healthcare & Pharmaceuticals

Diagnosing Long QT Syndrome

Novel approach for automatic ECG delineation and QT interval estimation, using an unsupervised learning model to diagnose and classify LQT syndrome.

By Queen’s University

Reference Number   08981

Last Update   May 04, 2022

Published
Healthcare & Pharmaceuticals

Synthesis of Thapsigargin

A synthetic method for the synthesis of thapsigargin and its analogs. The improved route is only 11 steps with 40 fold greater yield than previous methods.

By Kristy Reynald

Reference Number   09232

Last Update   Sep 15, 2022

Published
Healthcare & Pharmaceuticals

Novel CYP26A1 Inhibitors

A series of compounds was synthesized using rational drug-based design. These compounds represent significant improvements over other clinically tested CYP26 antagonists.

By Queen’s University

Reference Number   09233

Last Update   Sep 15, 2022

  • ‹
  • 1
  • 2
  • ›
Leading Edge Only
© 2025 Leading Edge Only LTD
  • About
  • About
  • Introduction
  • Corporates
  • Innovators
  • Members
  • Partners
  • Help
  • Contact Us
  • Help Center / FAQs
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Acceptable Use Policy
  • Supported Browsers
  • Functions
  • Add your Innovation
  • Create your Challenge
  • Search Innovations
  • Explore
  • Challenges
  • Collaborators
  • Innovations
  • Members
  • Universities
  • Content Hub
  • Case Studies
  • Resources
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
© 2025 Leading Edge Only LTD

Your experience on this site will be improved by allowing cookies.